Insider trades
Joshua B. Cohen, CEO of Amylyx Pharmaceuticals AMLX, has filed 0 purchases and 18 sales on the open market. Over the past 12 months that comes to a net sale of $2.6M. The latest trade was on 03/05.
Joshua B. Cohen
Co-CEO
- Company
- Amylyx Pharmaceuticals AMLX
- First filing
- 23/01/10
- Trades
- 38 trades
- Buys / sales
- 0 / 18
- 12-month net buying
- −$2.6M
- Last trade
- 03/05
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale | 03/02 | 03/04 | 29,282 sh | $14.48 | $424,003.36 | −0.9% | |
| Open-market sale | 02/02 | 02/04 | 15,500 sh | $14.68 | $227,540 | −0.5% | |
AMLX | Open-market sale | 01/15–01/16 | 01/20 | 138,167 sh2 trades | $13.59avg. | $1,878,163.29 | −3.9% |
| Open-market sale | 01/06 | 01/08 | 7,715 sh | $11.09 | $85,559.35 | −0.2% | |
AMLX | Open-market sale | 25/09/30 | 25/10/02 | 29,933 sh2 trades | $14.34avg. | $429,371.22 | −0.9% |
| Open-market sale | 25/03/31 | 25/04/02 | 21,490 sh | $3.47 | $74,570.3 | −0.6% | |
| Open-market sale | 25/03/03 | 25/03/05 | 4,595 sh | $3.17 | $14,566.15 | −0.1% | |
| Open-market sale | 25/02/03 | 25/02/05 | 11,851 sh | $3.47 | $41,122.97 | −0.4% | |
| Open-market sale | 25/01/06 | 25/01/08 | 7,471 sh | $4.05 | $30,257.55 | −0.2% | |
| Open-market sale | 24/09/30 | 24/10/02 | 18,589 sh | $3.20 | $59,484.8 | −0.6% | |
| Open-market sale | 24/03/05 | 24/03/07 | 4,135 sh | $18.73 | $77,448.55 | −0.1% | |
| Open-market sale | 24/01/09 | 24/01/11 | 5,841 sh | $16.33 | $95,383.53 | −0.2% | |
AMLX | Open-market sale | 23/03/16 | 23/03/20 | 100,000 sh2 trades | $31.86avg. | $3,186,393.64 | −3.5% |
AMLX | Open-market sale | 23/01/06 | 23/01/10 | 5,968 sh2 trades | $36.30avg. | $216,636.1 | +0.2% |